Diabetes Mellitus, Type 1

• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Guangzhou, China
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Hangzhou, China
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Harbin, China
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Hefei, China

• Sanofi-aventis — Moscow, Russia

• Sanofi-Aventis — Almaty, Kazakhstan

• Department of Clinical Pharmacology, Medical University of Vienna — Vienna, Austria

Not specified

• University of Washington, Diabetes Care Center — Seattle, Washington, United States

• Universitair Ziekenhuis Antwerpen — Antwerp, Belgium
• Universitair Ziekenhuis and Diabetes Research Center - Brussels Free University-VUB — Brussels, Belgium
• Hopital Erasme — Brussels, Belgium
• Department of Endocrinology and Nephrology, UZ Gasthuisberg, Katholieke Universiteit Leuven -KUL — Leuven, Belgium

• Profil Institut fur Stoffwechselforschung GmbH — Neuss, Germany

• John Muir Physician Network Clinical Research Center — Concord, California, United States
• Advanced Metabolic Care + Research — Escondido, California, United States
• Sansum Diabetes Research Institute — Santa Barbara, California, United States

• Department of Clinical Pharmacology, Medical University of Vienna — Vienna, Austria